📰 Nasdaq Tech News
Page 2 - Nasdaq Tech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Tech. Real-time updates on events, politics, business and more.
February 22, 2024
V Square Quantitative Management LLC raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 246.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,453 shares of the biotechnology company’s stock after acquiring an additional 2,457 shares during the quarter. […]
February 10, 2024
Victory Capital Management Inc. cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 19.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,360 shares of the biotechnology company’s stock after selling 7,783 shares during the period. […]
February 4, 2024
Dorsey & Whitney Trust CO LLC increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 155,984 shares of the biotechnology company’s stock after acquiring an additional 1,538 shares during the quarter. […]
February 2, 2024
Fox Run Management L.L.C. acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,898 shares of the biotechnology company’s stock, valued at approximately $401,000. Several other institutional investors and hedge funds have also […]
February 2, 2024
Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by equities researchers at Stephens from $92.00 to $87.00 in a research note issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the biotechnology company’s stock. Stephens’ target price would indicate a potential upside of 31.72% from the stock’s current […]
February 2, 2024
Bio-Techne (NASDAQ:TECH – Get Free Report) had its target price cut by investment analysts at Royal Bank of Canada from $85.00 to $75.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “sector perform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price target points to a potential […]
January 30, 2024
Teacher Retirement System of Texas increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.6% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 12,197 shares of the biotechnology company’s stock after buying an additional 306 shares during the quarter. Teacher Retirement System of Texas’ […]
January 17, 2024
Legacy Wealth Asset Management LLC lowered its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 16.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 7,436 shares of the biotechnology company’s stock after selling 1,500 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Bio-Techne were worth $506,000 as of […]
January 16, 2024
Securian Asset Management Inc. cut its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 11.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,252 shares of the biotechnology company’s stock after selling 1,464 shares during […]
January 16, 2024
Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 28.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 15,872 shares of the biotechnology company’s stock after buying an additional 3,502 shares during the […]